Story perspectives

Kenya Distributes HIV Vaccine, Excludes High-Need Kibera

4/1/2026

Summary

Story summary

Kenya has begun distributing lenacapavir, a potential HIV vaccine, with a goal of reducing new infections by 2030.
The rollout, however, excludes Kibera, a high-prevalence informal settlement, fueling concerns about equitable access.
The rollout will distribute 21,000 doses across 15 counties, but residents face transport costs to distant clinics.
Experts say without targeted policies and community-based delivery, access will remain uneven, limiting benefits for those in need.

1 of 1

Story summary

Kenya has begun distributing lenacapavir, a potential HIV vaccine, with a goal of reducing new infections by 2030.
The rollout, however, excludes Kibera, a high-prevalence informal settlement, fueling concerns about equitable access.
The rollout will distribute 21,000 doses across 15 counties, but residents face transport costs to distant clinics.
Experts say without targeted policies and community-based delivery, access will remain uneven, limiting benefits for those in need.